M. Hanief Sofi

1.0k total citations
31 papers, 738 citations indexed

About

M. Hanief Sofi is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, M. Hanief Sofi has authored 31 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 12 papers in Molecular Biology and 8 papers in Hematology. Recurrent topics in M. Hanief Sofi's work include Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (11 papers) and Hematopoietic Stem Cell Transplantation (7 papers). M. Hanief Sofi is often cited by papers focused on Immune Cell Function and Interaction (17 papers), T-cell and B-cell Immunology (11 papers) and Hematopoietic Stem Cell Transplantation (7 papers). M. Hanief Sofi collaborates with scholars based in United States, China and India. M. Hanief Sofi's co-authors include Radhika Gudi, Benjamin M. Johnson, Chenthamarakshan Vasu, Cheong‐Hee Chang, Xue‐Zhong Yu, Subha Karumuthil‐Melethil, Nicolas Pérez, Yongxia Wu, David Bastian and Steven Schutt and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Blood.

In The Last Decade

M. Hanief Sofi

30 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Hanief Sofi United States 16 356 331 102 92 80 31 738
Juan E. Viñuela Spain 17 218 0.6× 259 0.8× 47 0.5× 160 1.7× 76 0.9× 39 835
Daniel Peltier United States 14 232 0.7× 252 0.8× 116 1.1× 88 1.0× 27 0.3× 32 590
Akira Shiraishi Japan 16 414 1.2× 364 1.1× 88 0.9× 263 2.9× 67 0.8× 38 1.0k
Luis Miguel Guachalla Germany 14 138 0.4× 431 1.3× 107 1.0× 73 0.8× 54 0.7× 18 845
Xiaomin Yao China 12 308 0.9× 540 1.6× 32 0.3× 144 1.6× 64 0.8× 25 820
Ryusuke Nabeshima Japan 7 200 0.6× 176 0.5× 108 1.1× 133 1.4× 40 0.5× 9 491
Yasuo Suemoto Japan 10 388 1.1× 393 1.2× 54 0.5× 117 1.3× 42 0.5× 15 790
Kateryna Shkarina Switzerland 7 472 1.3× 1.0k 3.1× 96 0.9× 66 0.7× 27 0.3× 15 1.2k
Akira Okazawa Japan 14 419 1.2× 266 0.8× 59 0.6× 65 0.7× 228 2.9× 29 781

Countries citing papers authored by M. Hanief Sofi

Since Specialization
Citations

This map shows the geographic impact of M. Hanief Sofi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hanief Sofi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hanief Sofi more than expected).

Fields of papers citing papers by M. Hanief Sofi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hanief Sofi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hanief Sofi. The network helps show where M. Hanief Sofi may publish in the future.

Co-authorship network of co-authors of M. Hanief Sofi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hanief Sofi. A scholar is included among the top collaborators of M. Hanief Sofi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hanief Sofi. M. Hanief Sofi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schutt, Steven, Yongxia Wu, David Bastian, et al.. (2022). The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease. Journal of Clinical Investigation. 132(21). 14 indexed citations
2.
Sofi, M. Hanief, Linlu Tian, Steven Schutt, et al.. (2022). Ceramide synthase 6 impacts T-cell allogeneic response and graft-versus-host disease through regulating N-RAS/ERK pathway. Leukemia. 36(7). 1907–1915. 13 indexed citations
3.
Wu, Yongxia, Chih-Hang Anthony Tang, David Bastian, et al.. (2021). STING negatively regulates allogeneic T-cell responses by constraining antigen-presenting cell function. Cellular and Molecular Immunology. 18(3). 632–643. 5 indexed citations
4.
Bastian, David, Hung Nguyen, Yongxia Wu, et al.. (2021). Interleukin-23 receptor signaling by interleukin-39 potentiates T cell pathogenicity in acute graft-versus-host disease. American Journal of Transplantation. 21(11). 3538–3549. 8 indexed citations
5.
Sofi, M. Hanief, Yongxia Wu, Taylor Ticer, et al.. (2021). A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. JCI Insight. 6(3). 62 indexed citations
6.
Choi, Hee-Jin, Chih-Hang Anthony Tang, Linlu Tian, et al.. (2021). XBP-1s Promotes B Cell Pathogenicity in Chronic GVHD by Restraining the Activity of Regulated IRE-1α-Dependent Decay. Frontiers in Immunology. 12. 4 indexed citations
7.
Vaena, Silvia G., Paramita Chakraborty, Gyda Beeson, et al.. (2021). Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response. Cell Reports. 35(5). 109076–109076. 59 indexed citations
8.
Gudi, Radhika, Nicolas Pérez, Benjamin M. Johnson, et al.. (2019). Complex dietary polysaccharide modulates gut immune function and microbiota, and promotes protection from autoimmune diabetes. Immunology. 157(1). 70–85. 43 indexed citations
9.
10.
Daenthanasanmak, Anusara, Yongxia Wu, Supinya Iamsawat, et al.. (2018). PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity. Journal of Clinical Investigation. 128(7). 2787–2801. 27 indexed citations
11.
Wu, Yongxia, Steven Schutt, Katelyn Paz, et al.. (2018). MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice. Blood. 131(17). 1974–1986. 46 indexed citations
12.
Bastian, David, Yuejun Liu, Yongxia Wu, et al.. (2018). IL-27 Receptor Signaling on T cells Augments GVHD Severity through Enhancing Th1 Responses.. PubMed. 3(1). 151–157. 5 indexed citations
13.
Sofi, M. Hanief, Yongxia Wu, Min Dai, et al.. (2017). Oxidative Stress Regulates T Cell Pathogenicity in Gvhd. Blood. 130. 3168–3168. 1 indexed citations
14.
Sofi, M. Hanief, Jessica Heinrichs, Mohammed Dany, et al.. (2017). Ceramide synthesis regulates T cell activity and GVHD development. JCI Insight. 2(10). 51 indexed citations
15.
Karumuthil‐Melethil, Subha, M. Hanief Sofi, Radhika Gudi, et al.. (2014). TLR2- and Dectin 1–Associated Innate Immune Response Modulates T-Cell Response to Pancreatic β-Cell Antigen and Prevents Type 1 Diabetes. Diabetes. 64(4). 1341–1357. 25 indexed citations
16.
Qiao, Yu, Brian M. Gray, M. Hanief Sofi, et al.. (2012). Innate-like CD4 T cells selected by thymocytes suppress adaptive immune responses against bacterial infections. PubMed. 2(1). 25–39. 4 indexed citations
17.
Sofi, M. Hanief, et al.. (2010). Regulation of IL-17 expression by the developmental pathway of CD4 T cells in the thymus. Molecular Immunology. 47(6). 1262–1268. 8 indexed citations
18.
Sofi, M. Hanief, Wěi Li, Mark H. Kaplan, & Cheong‐Hee Chang. (2009). Elevated IL-6 expression in CD4 T cells via PKCθ and NF-κB induces Th2 cytokine production. Molecular Immunology. 46(7). 1443–1450. 21 indexed citations
19.
Li, Wei, M. Hanief Sofi, Svend T. Rietdijk, et al.. (2007). The SLAM-Associated Protein Signaling Pathway Is Required for Development of CD4+ T Cells Selected by Homotypic Thymocyte Interaction. Immunity. 27(5). 763–774. 61 indexed citations
20.
Patel, Dipak, Wei Li, M. Hanief Sofi, et al.. (2005). Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus. Cellular Immunology. 233(1). 30–40. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Juan E. Viñuela Breakdown of academic impact, for papers by Daniel Peltier Breakdown of academic impact, for papers by Akira Shiraishi Breakdown of academic impact, for papers by Luis Miguel Guachalla Breakdown of academic impact, for papers by Xiaomin Yao Breakdown of academic impact, for papers by Ryusuke Nabeshima Breakdown of academic impact, for papers by Yasuo Suemoto Breakdown of academic impact, for papers by Kateryna Shkarina Breakdown of academic impact, for papers by Akira Okazawa
Rankless by CCL
2026